Automatic Website Traffic Generator


US   France   Germany   Spain   Netherlands  

Synthetic THC drug Syndros poised for Schedule II classification | Latest News

Synthetic THC drug Syndros poised for Schedule II classification

A synthetic THC drug just cleared a federal regulatory hurdle to commercialization. Insys Therapeutics, a Chandler, Ariz.-based pharmaceutical firm, said Thursday its U.S. Food and Drug Administration-approved liquid dronabinol drug Syndros could launch ... read more

DEA awards Schedule II classification to synthetic THC drug

On March 23, 2017, the DEA announced it has scheduled the newly approved synthetic THC-containing drug, Syndros, as a Class II substance ... that the DEA would lessen the classification of cannabis to a Schedule II substance, which are defined as drugs ... read more

DEA Approves Synthetic Cannabis “Syndros” As Schedule II

The DEA has classified Syndros, Insys Therapeutics’ synthetic marijuana product that mirrors compounds seen in the cannabis plant, as Schedule II ... drugs, namely cannabis. Earlier, the company had petitioned the DEA for changing Syndros from ... read more

DEA approves synthetic marijuana for big pharma company against legalization

A synthetic ... a newly approved drug a schedule II classification. On Thursday, Insys Therapeutics announced that the Drug Enforcement Administration (DEA) issued an interim final rule that would put Syndros, their synthetic marijuana drug, on Schedule ... read more

DEA Approves Synthetic Marijuana for Company That Spent $500K to Keep Weed Illegal

A synthetic ... a newly approved drug a schedule II classification. On Thursday, Insys Therapeutics announced that the Drug Enforcement Administration (DEA) issued an interim final rule that would put Syndros, their synthetic marijuana drug, on Schedule ... read more

DEA Awards Synthetic Cannabis Drug with Schedule II Status

All cannabis in the United States is classified under Schedule I, the most restrictive classification possible under the Control Substances Act. A drug containing synthetic ... like Syndros are classified in the more restrictive Schedule II because ... read more

Insys cannabinoid drug Syndros given Schedule II status

Syndros is a liquid, oral version of AbbVie's drug Marinol. Both drugs are synthetic versions of tetrahydrocannabinol, part of an active compounds group called cannabinoids that are found in marijuana ... Syndros' classification from Schedule I to ... read more

DEA awards Schedule II classification to synthetic THC drug

Arizona appellate court takes the high road and enforces a commercial lease to operate a medical marijuana dispensary On March 23, 2017, the DEA announced it has scheduled the newly approved synthetic THC-containing drug, Syndros, as a Class II substance. read more

DEA Classifies Synthetic THC Drug As Schedule II

the synthetic THC-substitute––the Drug Enforcement Administration classified Syndros as Schedule II under the Controlled Substances Act. The DEA designation has Syndros in a class of drugs considered to be less dangerous than actual weed. And the ... read more
Popular RSS Feeds: att business identity management no taxation without representation allergan direct cognoscente ira hayes crema cafe njchildsupport accept credit cards online reformulate benefits of cloud computing rulet reliable heating and air your mom goes to college denver dui attorney region rhone alpes sangertown mall renters insurance california pet food direct coupon ozil injury malaga bank steam inventory


Buy AutoTrafficRSS script now for $27 only!

We will send the script to your PayPal email within few hours,
Please add FullContentRSS@gmail.com to your email contact.



Auto Traffic generator Powered by. Full RSS Feed | Article Generator | Contact Us